Atlas Trials

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants

Clinical trial NCT02334982 · COMPLETED

Trial details

NCT number
NCT02334982
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dose Finding Study
Start date
2013-06-01
Primary completion
2014-01-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.